Ceribell (CBLL) Income towards Parent Company (2023 - 2026)
Ceribell's (CBLL) quarterly Income towards Parent Company came in at -$19.7 million in Q1 2026, down 54.47% YoY from -$43.4 million in Q1 2025, and down 45.91% on a QoQ basis from -$13.5 million in Q4 2025.
Ceribell (CBLL) Income towards Parent Company (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Income towards Parent Company data on file, last reported at -$19.7 million in Q1 2026.
- Quarterly Income towards Parent Company fell 54.47% year-over-year to -$19.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.4 million (down 35.03% YoY) and the FY2025 annual result came in at -$54.0 million, down 69.15% from the prior year.
- Income towards Parent Company fell to -$19.7 million in Q1 2026, from -$13.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$7.1 million in Q3 2023 to a low of -$19.7 million in Q1 2026.
- A 4-year average of -$11.7 million and a median of -$12.6 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2025 — Income towards Parent Company slipped 7.56% — and 2026, when it tumbled 54.47%.
- Tracing CBLL's Income towards Parent Company over 4 years: stood at -$8.3 million in 2023, then sank by 51.99% to -$12.6 million in 2024, then decreased by 7.56% to -$13.5 million in 2025, then slumped by 45.91% to -$19.7 million in 2026.
- The last three Income towards Parent Company figures came in at -$19.7 million (Q1 2026), -$13.5 million (Q4 2025), and -$13.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Ceribell | 927.79 Mn | 798.53 Mn | 25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.27 Mn |
| Mar 31, 2026 | -19.74 Mn |
| Dec 31, 2025 | -13.53 Mn |
| Sep 30, 2025 | -13.47 Mn |
| Jun 30, 2025 | -13.64 Mn |
| Mar 31, 2025 | -12.78 Mn |
| Dec 31, 2024 | -12.58 Mn |
| Sep 30, 2024 | -10.42 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -8.52 Mn |
| Dec 31, 2023 | -8.27 Mn |
| Sep 30, 2023 | -7.05 Mn |